Literature DB >> 19874218

The structure, genetic polymorphisms, expression and biological functions of complement receptor type 1 (CR1/CD35).

Dong Liu1, Zhong-Xiang Niu.   

Abstract

The complement system is comprised of soluble and cell surface associated proteins that recognize exogenous, altered, or potentially harmful endogenous ligands. In recent years, the complement system--particularly component C3 and its receptors--have been demonstrated to be a key link between innate and adaptive immunity. Complement receptor type 1 (CR1), the receptor for C3b/C4b complement peptides, has emerged as a molecule of immense interest in gaining insight to the susceptibility, pathophysiology, diagnosis, prognosis and therapy of such diseases. In this review, we wish to briefly bring forth the structure, genetic polymorphisms, expression and biological functions of CR1.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19874218     DOI: 10.3109/08923970902845768

Source DB:  PubMed          Journal:  Immunopharmacol Immunotoxicol        ISSN: 0892-3973            Impact factor:   2.730


  30 in total

Review 1.  Protein engineering to target complement evasion in cancer.

Authors:  Darrick Carter; André Lieber
Journal:  FEBS Lett       Date:  2013-11-14       Impact factor: 4.124

2.  Complement receptor 1 gene variants are associated with erythrocyte sedimentation rate.

Authors:  Iftikhar J Kullo; Keyue Ding; Khader Shameer; Catherine A McCarty; Gail P Jarvik; Joshua C Denny; Marylyn D Ritchie; Zi Ye; David R Crosslin; Rex L Chisholm; Teri A Manolio; Christopher G Chute
Journal:  Am J Hum Genet       Date:  2011-06-23       Impact factor: 11.025

3.  Detection of Genetic Rearrangements in the Regulators of Complement Activation RCA Cluster by High-Throughput Sequencing and MLPA.

Authors:  Jesús García-Fernández; Susana Vilches-Arroyo; Leticia Olavarrieta; Julián Pérez-Pérez; Santiago Rodríguez de Córdoba
Journal:  Methods Mol Biol       Date:  2021

Review 4.  CR1 in Alzheimer's disease.

Authors:  Xi-Chen Zhu; Jin-Tai Yu; Teng Jiang; Ping Wang; Lei Cao; Lan Tan
Journal:  Mol Neurobiol       Date:  2014-05-04       Impact factor: 5.590

5.  Peripheral complement interactions with amyloid β peptide in Alzheimer's disease: 2. Relationship to amyloid β immunotherapy.

Authors:  Andrés Crane; William D Brubaker; Jenny U Johansson; Abhishek Trigunaite; Justine Ceballos; Bonnie Bradt; Courtney Glavis-Bloom; Tanya L Wallace; Andrea J Tenner; Joseph Rogers
Journal:  Alzheimers Dement       Date:  2017-07-26       Impact factor: 21.566

Review 6.  [Search for risk genes in Alzheimer's disease].

Authors:  I Karaca; H Wagner; A Ramirez
Journal:  Nervenarzt       Date:  2017-07       Impact factor: 1.214

7.  Up regulated complement and fc receptors in juvenile idiopathic arthritis and correlation with disease phenotype.

Authors:  Kajsa E Prokopec; Lillemor Berntson; Anders Öman; Sandra Kleinau
Journal:  J Clin Immunol       Date:  2012-02-11       Impact factor: 8.317

Review 8.  Alzheimer's disease genetics: from the bench to the clinic.

Authors:  Celeste M Karch; Carlos Cruchaga; Alison M Goate
Journal:  Neuron       Date:  2014-07-02       Impact factor: 17.173

9.  A coding variant in CR1 interacts with APOE-ε4 to influence cognitive decline.

Authors:  Brendan T Keenan; Joshua M Shulman; Lori B Chibnik; Towfique Raj; Dong Tran; Mert R Sabuncu; April N Allen; Jason J Corneveaux; John A Hardy; Matthew J Huentelman; Cynthia A Lemere; Amanda J Myers; Anne Nicholson-Weller; Eric M Reiman; Denis A Evans; David A Bennett; Philip L De Jager
Journal:  Hum Mol Genet       Date:  2012-02-17       Impact factor: 6.150

Review 10.  Alzheimer's disease risk genes and mechanisms of disease pathogenesis.

Authors:  Celeste M Karch; Alison M Goate
Journal:  Biol Psychiatry       Date:  2014-05-17       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.